The Journal of Neuroscience, October 14, 2009, 29(41):12776-12786; doi:10.1523/JNEUROSCI.3463-09.2009
Previous Article | Next Article 
Symposia and Mini-Symposia
Axonal Transport Defects in Neurodegenerative Diseases
Gerardo A. Morfini,1
Matthew Burns,1
Lester I. Binder,2
Nicholas M. Kanaan,2
Nichole LaPointe,2
Daryl A. Bosco,3
Robert H. Brown Jr,3
Hannah Brown,4
Ashutosh Tiwari,5
Lawrence Hayward,3
Julia Edgar,6
Klaus-Armin Nave,7
James Garberrn,8
Yuka Atagi,1
Yuyu Song,1
Gustavo Pigino,1 and
Scott T. Brady1
1Department of Anatomy and Cell Biology, University of Illinois at Chicago, Chicago, Illinois 60612, 2Department of Cell and Molecular Biology, Feinberg School of Medicine, Northwestern University, Chicago, Illinois 60611, 3Department of Neurology, University of Massachusetts Medical Center, Worcester, Massachusetts 01655, 4Department of Psychiatry, Massachusetts General Hospital, Boston, Massachusetts 02114, 5Department of Chemistry, Michigan Technological University, Houghton, Michigan 49931, 6Applied Neurobiology Group, Division of Cell Sciences, Institute of Comparative Medicine, University of Glasgow, G61 1QH Glasgow, Scotland, 7Department of Neurogenetics, Max Planck Institute of Experimental Medicine, D-37075 Göttingen, Germany, and 8Department of Neurology and Center for Molecular Medicine and Genetics, Wayne State University School of Medicine, Detroit, Michigan 48201
Correspondence should be addressed to Dr. Gerardo A. Morfini, Department of Anatomy and Cell Biology, University of Illinois at Chicago, MC512, 909 South Wolcott Street, COMRB Room 6051, Chicago, IL 60612. Email: gmorfini{at}uic.edu
Adult-onset neurodegenerative diseases (AONDs) comprise a heterogeneous group of neurological disorders characterized by a progressive, age-dependent decline in neuronal function and loss of selected neuronal populations. Alterations in synaptic function and axonal connectivity represent early and critical pathogenic events in AONDs, but molecular mechanisms underlying these defects remain elusive. The large size and complex subcellular architecture of neurons render them uniquely vulnerable to alterations in axonal transport (AT). Accordingly, deficits in AT have been documented in most AONDs, suggesting a common defect acquired through different pathogenic pathways. These observations suggest that many AONDs can be categorized as dysferopathies, diseases in which alterations in AT represent a critical component in pathogenesis. Topics here address various molecular mechanisms underlying alterations in AT in several AONDs. Illumination of such mechanisms provides a framework for the development of novel therapeutic strategies aimed to prevent axonal and synaptic dysfunction in several major AONDs.
Received July 17, 2009;
accepted Aug. 4, 2009.
Correspondence should be addressed to Dr. Gerardo A. Morfini, Department of Anatomy and Cell Biology, University of Illinois at Chicago, MC512, 909 South Wolcott Street, COMRB Room 6051, Chicago, IL 60612. Email: gmorfini{at}uic.edu
eLetters:
Read all eLetters
- Neurofilaments in axonal neuropathy
- Heikki Savolainen
- J. Neurosci. Online, 16 Oct 2009
[Full text]